Almirall, S.A. (BME:ALM)
Spain
· Delayed Price · Currency is EUR 10.42
-0.38 (-3.52%)
May 13, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Commercialization through Own Network | 708.64M |
Log In |
Log In |
Log In |
Log In |
| Commercialization through Own Network Growth | 7.64% |
Log In |
Log In |
Log In |
Log In |
| Commercialization through Licensees | 88.22M |
Log In |
Log In |
Log In |
Log In |
| Commercialization through Licensees Growth | 1.97% |
Log In |
Log In |
Log In |
Log In |
| Dermatology in the United States | 57.49M |
Log In |
Log In |
Log In |
Log In |
| Dermatology in the United States Growth | -22.50% |
Log In |
Log In |
Log In |
Log In |
| Corporate Management and Results Not Assigned to Other Segments | 40.18M |
Log In |
Log In |
Log In |
Log In |
| Corporate Management and Results Not Assigned to Other Segments Growth | -9.15% |
Log In |
Log In |
Log In |
Log In |
| Research and Development Activity | - |
Log In |
Log In |
Log In |
Log In |
| Research and Development Activity Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Spain | 296.92M |
Log In |
Log In |
Log In |
Log In |
| Spain Growth | 8.42% |
Log In |
Log In |
Log In |
Log In |
| Germany | 217.58M |
Log In |
Log In |
Log In |
Log In |
| Germany Growth | 6.41% |
Log In |
Log In |
Log In |
Log In |
| Europe and the Middle East | 128.65M |
Log In |
Log In |
Log In |
Log In |
| Europe and the Middle East Growth | 34.82% |
Log In |
Log In |
Log In |
Log In |
| Italy | 74.83M |
Log In |
Log In |
Log In |
Log In |
| Italy Growth | 22.51% |
Log In |
Log In |
Log In |
Log In |
| United States | 57.49M |
Log In |
Log In |
Log In |
Log In |
| United States Growth | -22.50% |
Log In |
Log In |
Log In |
Log In |
| America, Asia and Africa | 48.55M |
Log In |
Log In |
Log In |
Log In |
| America, Asia and Africa Growth | -6.61% |
Log In |
Log In |
Log In |
Log In |
| France | 42.71M |
Log In |
Log In |
Log In |
Log In |
| France Growth | 21.32% |
Log In |
Log In |
Log In |
Log In |
| United Kingdom | 27.80M |
Log In |
Log In |
Log In |
Log In |
| United Kingdom Growth | 21.78% |
Log In |
Log In |
Log In |
Log In |
| Corporate Management and Revenue Not Allocated to Other Segments | - |
Log In |
Log In |
Log In |
Log In |
| Corporate Management and Revenue Not Allocated to Other Segments Growth | - |
Log In |
Log In |
Log In |
Log In |